Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Thiocolchicoside in Cervical Myofascial Pain Syndrome
NCT00272532Phase 4Completed
- Sponsor
- Sanofi
- Start
- Apr 2005
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of thiocolchicoside in myofascial pain syndrome (MPS) (3 arms), sponsored by Sanofi. Primary endpoints: Pain relief, Increase in mobility of neck and 1 more. Started Apr 2005; status: completed.
02
Drugs
thiocolchicoside
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT00272532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00272532.